Skip to main content

Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 136–150 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5310
GTPBP2 Gene Neurodegeneration with Brain Iron Accumulation Genetic Test

This test detects pathogenic variants in the entire coding region of the GTPBP2 gene associated with neurodegeneration with brain iron accumulation (NBIA).

Whole Blood (Peripheral) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GTPBP2 gene", "Single nucleotide variants", "Small deletions/duplications", "Copy number changes"]
Parameters
[]
Preparation
["No fasting or dietary changes are required.", "Provide clinical history and relevant medical reports."]
Indications
["Individuals with clinical features suggestive of NBIA", "Family members of individuals diagnosed with NBIA", "Differential diagnosis of neurodegenerative disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G23.0
Clinical summary
This test detects pathogenic variants in the entire coding region of the GTPBP2 gene associated with neurodegeneration with brain iron accumulation (NBIA).
TEST-2798
HOXA13 Gene Guttmacher Syndrome Genetic Test

This genetic test evaluates the HOXA13 gene for pathogenic variants associated with Guttmacher syndrome.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HOXA13 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)"]
Parameters
[]
Preparation
["Fasting is not required", "Maintain adequate hydration"]
Indications
["Diagnosis of Guttmacher syndrome", "Genetic counseling for reproductive planning", "Identification of pathogenic variants in HOXA13"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48007-2 ICD-10: Q87.8
Clinical summary
This genetic test evaluates the HOXA13 gene for pathogenic variants associated with Guttmacher syndrome.
TEST-4200
HPCA Gene DYT2 Genetic Test

This test evaluates the HPCA gene for pathogenic variants associated with autosomal dominant dystonia type 2 (DYT2).

Whole Blood (Peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HPCA gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy-number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the lab of any recent blood transfusions"]
Indications
["Diagnosis of autosomal dominant dystonia type 2 (DYT2)", "Genetic counseling for families with DYT2", "Confirmation of clinical suspicion in patients with dystonia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92558-8 ICD-10: G24.2
Clinical summary
This test evaluates the HPCA gene for pathogenic variants associated with autosomal dominant dystonia type 2 (DYT2).
TEST-6248
HPD Gene Hawkinsinuria Genetic Test

This genetic test identifies pathogenic variants in the HPD gene associated with Hawkinsinuria (tyrosinemia type III). It provides a definitive molecular diagnosis for this metabol...

Peripheral Whole Blood, Serum, or Plasma (Blood Draw) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HPD gene", "Full coding region and splice sites of the HPD gene"]
Parameters
[]
Preparation
["Genetic counselling session recommended", "Maintain prescribed low-tyrosine formula or emergency protocols if applicable"]
Indications
["Suspected Hawkinsinuria (tyrosinemia type III)", "Family history of Hawkinsinuria", "Need for definitive molecular diagnosis for dietary management", "Proactive family screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81311-6 ICD-10: E70.29
Clinical summary
This genetic test identifies pathogenic variants in the HPD gene associated with Hawkinsinuria (tyrosinemia type III). It provides a definitive molecular diagnosis for this metabolic disorder.
TEST-5012
HPGD Gene Hypertrophic Osteoarthropathy Type 1 Genetic Test

This test sequences the HPGD gene to identify pathogenic variants associated with Primary Hypertrophic Osteoarthropathy Type 1 (PHOAR1). It confirms or excludes the diagnosis of th...

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HPGD gene sequence", "Pathogenic variants in HPGD gene"]
Parameters
[]
Preparation
["No specific fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected Primary Hypertrophic Osteoarthropathy Type 1 (PHOAR1)", "Differentiation from secondary causes of hypertrophic osteoarthropathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: M89.41
Clinical summary
This test sequences the HPGD gene to identify pathogenic variants associated with Primary Hypertrophic Osteoarthropathy Type 1 (PHOAR1). It confirms or excludes the diagnosis of this specific genetic disorder.
TEST-2206
HPSE2 Gene Urofacial Syndrome Type 1 Genetic Test

This test identifies pathogenic variants within the HPSE2 gene associated with Urofacial Syndrome Type 1.

Whole blood (3–5 mL in EDTA tube) or extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HPSE2 gene", "Copy number variants (CNV) in the HPSE2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Urofacial Syndrome Type 1 (Ochoa Syndrome)", "Family history of Urofacial Syndrome Type 1", "Need for genetic counseling and family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101886-4 ICD-10: Q87.0, Q64.8, Z13.79
Clinical summary
This test identifies pathogenic variants within the HPSE2 gene associated with Urofacial Syndrome Type 1.
TEST-3717
HS6ST1 Gene Hypogonadotropic Hypogonadism Type 15 (With/Without Anosmia) Genetic Test

This genetic test identifies mutations in the HS6ST1 gene associated with Hypogonadotropic Hypogonadism Type 15, often linked to anosmia.

Peripheral Whole Blood (EDTA) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HS6ST1 gene variants", "Disease-causing mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current hormonal therapy"]
Indications
["Diagnosis of Hypogonadotropic Hypogonadism Type 15", "Evaluation of infertility", "Genetic counseling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82376-6 ICD-10: E23.0
Clinical summary
This genetic test identifies mutations in the HS6ST1 gene associated with Hypogonadotropic Hypogonadism Type 15, often linked to anosmia.
TEST-5559
HSD17B4 Gene Perrault Syndrome Genetic Test

This genetic test identifies pathogenic variants in the HSD17B4 gene associated with Perrault syndrome.

Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HSD17B4 gene coding sequence", "Pathogenic variants", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Clinical diagnosis confirmation", "Carrier screening", "Reproductive decision guidance", "Family history of Perrault syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83525-9 ICD-10: Q87.8
Clinical summary
This genetic test identifies pathogenic variants in the HSD17B4 gene associated with Perrault syndrome.
TEST-6014
HSD3B2 Gene 3‑Beta‑Hydroxysteroid Dehydrogenase Deficiency Type 2 Genetic Test

This genetic test identifies pathogenic variants in the HSD3B2 gene associated with 3-beta-hydroxysteroid dehydrogenase deficiency type 2.

Peripheral Whole Blood (Venipuncture), Extracted DNA, or FTA Card 3 to 4 weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HSD3B2 gene", "Full gene coverage analysis"]
Parameters
[]
Preparation
["Genetic counseling session mandatory before testing", "Family pedigree chart required"]
Indications
["Diagnosis of congenital adrenal hyperplasia", "Carrier testing for families", "Prenatal counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81216-7 ICD-10: E25.0
Clinical summary
This genetic test identifies pathogenic variants in the HSD3B2 gene associated with 3-beta-hydroxysteroid dehydrogenase deficiency type 2.
TEST-6131
HSD3B7 Gene (Bile Acid Synthesis Defect Type 1, Congenital) Genetic Test

This genetic test evaluates the HSD3B7 gene for variants associated with congenital bile acid synthesis defect type 1 (BASD1). It helps confirm the diagnosis in individuals suspect...

Peripheral Whole Blood, FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HSD3B7 gene", "Deletions and duplications within the HSD3B7 gene"]
Parameters
[]
Preparation
["No specific fasting required for blood draw", "Inform phlebotomist of any medications"]
Indications
["Infants with unexplained cholestasis", "Siblings of individuals diagnosed with BASD1", "Adults with late-onset atypical liver disease suspected to have a metabolic cause"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81825-0 ICD-10: E80.7
Clinical summary
This genetic test evaluates the HSD3B7 gene for variants associated with congenital bile acid synthesis defect type 1 (BASD1). It helps confirm the diagnosis in individuals suspected of having this rare metabolic liver disorder.
TEST-3327
HSPA9 Gene Analysis (Sideroblastic Anemia Type 4) Genetic Test

This genetic test identifies pathogenic variants in the HSPA9 gene associated with hereditary sideroblastic anemia type 4.

Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HSPA9 gene"]
Parameters
[]
Preparation
["No fasting required", "Avoid heavy physical exercise and alcohol 24 hours before the draw", "No medication changes unless advised by your doctor"]
Indications
["Suspected hereditary sideroblastic anaemia type 4", "Carrier screening", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D64.0, Z15.09, Z14.8
Clinical summary
This genetic test identifies pathogenic variants in the HSPA9 gene associated with hereditary sideroblastic anemia type 4.
TEST-5582
HSPG2 Gene Schwartz-Jampel Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the HSPG2 gene associated with Schwartz-Jampel syndrome type 1.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HSPG2 gene coding regions", "Conserved splice sites"]
Parameters
[]
Preparation
["No special dietary or medication preparation is needed before collection."]
Indications
["Suspected Schwartz-Jampel syndrome type 1", "Individuals with clinical features suggestive of chondrodystrophic myotonia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77678-5 ICD-10: G71.1, Z15.09, Q78.8
Clinical summary
This test identifies pathogenic variants in the HSPG2 gene associated with Schwartz-Jampel syndrome type 1.
TEST-2737
HYLS1 Gene Hydrolethalus Syndrome Genetic Test

This genetic test identifies pathogenic variants in the HYLS1 gene associated with hydrolethalus syndrome.

Whole blood (EDTA), extracted DNA, or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in HYLS1 gene"]
Parameters
[{"name": "HYLS1 Gene Coverage", "reference_range": "Targeted 100% coverage of HYLS1 coding regions"}]
Preparation
["Inform phlebotomist of any bleeding disorders or anticoagulant therapy"]
Indications
["Prenatal ultrasound findings suggestive of hydrolethalus syndrome", "Family history of hydrolethalus syndrome", "Carrier screening for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94039-6 ICD-10: Q87.8
Clinical summary
This genetic test identifies pathogenic variants in the HYLS1 gene associated with hydrolethalus syndrome.
TEST-2576
IER3IP1 Gene (Microcephaly, Epilepsy, Diabetes Syndrome) Genetic Test

This genetic test analyzes the IER3IP1 gene to identify mutations associated with microcephaly, epilepsy, and diabetes syndrome (MEDS). It helps confirm a diagnosis in patients wit...

Whole blood (EDTA tube), extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["IER3IP1 gene sequence", "Pathogenic variants (SNVs, indels, splice-site variants)"]
Parameters
[]
Preparation
["No fasting required", "Inform laboratory of recent blood transfusions or bone marrow transplants"]
Indications
["Patients with classic MEDS triad", "Sibling carrier testing", "Affected individual family studies", "Preconception counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92879-1 ICD-10: Q87.89, Q02, E10.8, G40.9
Clinical summary
This genetic test analyzes the IER3IP1 gene to identify mutations associated with microcephaly, epilepsy, and diabetes syndrome (MEDS). It helps confirm a diagnosis in patients with suggestive clinical features.
TEST-4769
IFNGR1 Gene Genetic Test (Atypical Familial Disseminated Mycobacterial Infection)

This test evaluates the IFNGR1 gene for pathogenic variants associated with Mendelian Susceptibility to Mycobacterial Disease (MSMD). It identifies mutations causing severe, recurr...

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["IFNGR1 gene sequence", "Copy Number Variations (CNV) in IFNGR1 gene", "Pathogenic variants in IFNGR1 gene"]
Parameters
[{"name": "IFNGR1 Gene Sequencing", "reference_range": null}, {"name": "CNV Detection", "reference_range": null}]
Preparation
["No specific fasting required", "Inform lab of any medications or conditions"]
Indications
["Diagnosis of Mendelian Susceptibility to Mycobacterial Disease (MSMD)", "Differentiation from other primary immunodeficiencies", "Genetic counselling for affected families", "Guiding prophylactic antimicrobial therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: D84.8
Clinical summary
This test evaluates the IFNGR1 gene for pathogenic variants associated with Mendelian Susceptibility to Mycobacterial Disease (MSMD). It identifies mutations causing severe, recurrent, or atypical disseminated mycobacterial infections.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.